Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab

We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement.

Detalles Bibliográficos
Autores principales: Bowens, Brendan K., Chou, Eva, LaChance, David P., Huynh, James R., Voorhees, Patrick, Do, Thanh C., Shakir, Mohamed K. M., Hoang, Thanh D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675368/
https://www.ncbi.nlm.nih.gov/pubmed/36415714
http://dx.doi.org/10.1002/ccr3.6621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675368/
https://www.ncbi.nlm.nih.gov/pubmed/36415714
http://dx.doi.org/10.1002/ccr3.6621

Ejemplares similares